Purpose: To determine whether the fusion of multiparametric magnetic resonance imaging (MRI) with transrectal real-time elastography (RTE) improves the visualization of PCa lesions compared to MRI alone.
Materials and Methods: In a prospective setting, 45 patients with biopsy-proven PCa received prostate MRI prior to radical prostatectomy (RP). T2 and diffusion-weighted imaging (T2WI/DW-MRI) and, if applicable, dynamic contrast-enhanced sequences (T2WI/DW/DCE-MRI) were used to perform MRI/RTE fusion. The probability of PCa on MRI was graded according to the PI-RADS score for 12 different prostate sectors per patient. MRI images were fused with RTE to stratify suspicious from non-suspicious sectors. Imaging results were compared to whole mount sections using nonparametrical receiver operating characteristic curves and the area under these curves (AUC).
Results: 41 of 45 patients were eligible for final analyses. Histopathology confirmed PCa in 261 (53 %) of 492 prostate sectors. MRI alone provided an AUC of 0.62 (T2WI/DW-MRI) and 0.65 (T2WI/DW/DCE-MRI) to predict PCa and was meaningfully enhanced to 0.75 (T2WI/DW-MRI) and 0.74 (T2WI/DW/DCE-MRI) using MRI/RTE fusion. Sole MRI showed a sensitivity and specificity of 57.9 % and 61 % with the best results for ventral prostate sectors whereas RTE was superior in dorsal and apical sectors. MRI/RTE fusion improved sensitivity and specificity to 65.9 % and 75.3 %, respectively. Additional use of DCE sequences showed a sensitivity and specificity of 65 % and 55.7 % for MRI and 72.1 % and 66 % for MRI/RTE fusion.
Conclusion: MRI/RTE fusion provides improved PCa visualization by combining the strength of both imaging techniques in regard to prostate zonal anatomy and thereby might improve future biopsy-guided PCa detection.
Written by:
Brock M, Roghmann F, Sonntag C, Sommerer F, Tian Z, Löppenberg B, Palisaar RJ, Noldus J, Hanske J, von Bodman C. Are you the author?
Urology, Ruhr-University Bochum, Marienhospital Herne; Radiology, Ruhr-University Bochum, Marienhospital Herne; Pathology, Ruhr-University Bochum, Berufsgenossenschaftliche Universitätsklinik Bergmannsheil GmbH, Bochum; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal.
Reference: Ultraschall Med. 2014 May 22. Epub ahead of print.
PubMed Abstract
PMID: 24854132
UroToday.com Prostate Cancer Section
